JP2008534524A5 - - Google Patents

Download PDF

Info

Publication number
JP2008534524A5
JP2008534524A5 JP2008503342A JP2008503342A JP2008534524A5 JP 2008534524 A5 JP2008534524 A5 JP 2008534524A5 JP 2008503342 A JP2008503342 A JP 2008503342A JP 2008503342 A JP2008503342 A JP 2008503342A JP 2008534524 A5 JP2008534524 A5 JP 2008534524A5
Authority
JP
Japan
Prior art keywords
skin
personal care
care product
methyl
whitening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008503342A
Other languages
Japanese (ja)
Other versions
JP2008534524A (en
Filing date
Publication date
Priority claimed from GBGB0506263.3A external-priority patent/GB0506263D0/en
Application filed filed Critical
Publication of JP2008534524A publication Critical patent/JP2008534524A/en
Publication of JP2008534524A5 publication Critical patent/JP2008534524A5/ja
Pending legal-status Critical Current

Links

Claims (15)

ヒト皮膚の美容美白のための皮膚美白化合物の使用であって、前記皮膚美白化合物が、２−［２−（４−メチル−３−シクロヘキセン−１−イル）−プロピル］−シクロペンタノン、６−イソプロピル−オクタヒドロ−ナフタレン−２−オン、４，７，７−トリメチル−２−（３−メチル−ブト−２−エニル）−ビシクロ［４．１．０］ヘプタン−３−オン、１−（５，６，７，８−テトラヒドロ−３，５，５，６，８，８−ヘキサメチル−２−ナフタル−エニル）−エタノン、１，１，２，３，３，８−ヘキサメチル−１，２，３，５，７，８−ヘキサヒドロ−６−オキサ−シクロペンタ［ｂ］ナフタレン、６，７−エポキシ−１，１，２，４，４，７−ヘキサメチル−オクタヒドロ−ナフタレン、１，１，２，３，３−ペンタメチル−１，２，３，５，６，７−ヘキサヒドロ−インデン−４−オン、１−（２，３，８，８−テトラメチル−１，２，３，４，５，６，７，８−オクタヒドロ−ナフタレン−２−イル）−エタノン、２，２，３’，７’，７’−ペンタメチルスピロ（１，３−ジオキサン−５，２’−ノルカラン）、メチル−ｎ−３，７−ジメチル−７−ヒドロキシオクチリデンアントラニラート、２−［３−（４−ｔｅｒｔ−ブチル−フェニル）−２−メチル−プロペニルアミノ］−安息香酸メチルエステル、２−［（２，４−ジメチル−シクロヘキス−３−エニルメチレン）−アミノ］−安息香酸メチルエステル、２−メチル−４−（２，６，６−トリメチル−シクロヘキス−２−エニル）−ブチルアルデヒド、３−（３−イソプロピル−フェニル）−ブチルアルデヒド、３−（４−イソブチル−フェニル）−２−メチル−プロピオンアルデヒド、［１−メチル−２−（１，２，２，−トリメチル−ビシクロ［３．１．０］ヘキス−３−イルメチル）−シクロプロピル］−メタノール、２−エチル−４−（２，２，３−トリメチル−シクロペント−３−エン−１−イル）−ブト−２−エン−１−オール、３−（５，５，６−トリメチルビシクロ［２．２．１］ヘプト−２−イル）シクロヘキサノール、３−（５，５，６−トリメチルビシクロ［２．２．１］ヘプト−２−イル）シクロヘキサノールを含有するサンデラプロセスの製品、３−メチル−５−（２，２，３−トリメチル−シクロペント−３−エニル）−ペンタン−２−オール、３−メチル−５−（２，２，３−トリメチル−３−シクロペンテン−１−イル）−４−ペンテン−２−オール、（ｅ）−オキサシクロヘプタデク−１０−エン−２−オン、３−メチルシクロテトラデク−５−エン−１−オン、４−メチルシクロテトラデク−６−エン−１−オン、およびオキサシクロヘキサデク−１２−エン−２−オンからなる群から選択される、前記使用。   Use of a skin whitening compound for cosmetic whitening of human skin, wherein the skin whitening compound is 2- [2- (4-methyl-3-cyclohexen-1-yl) -propyl] -cyclopentanone, 6 -Isopropyl-octahydro-naphthalen-2-one, 4,7,7-trimethyl-2- (3-methyl-but-2-enyl) -bicyclo [4.1.0] heptane-3-one, 1- ( 5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthalenyl) -ethanone, 1,1,2,3,3,8-hexamethyl-1,2 , 3,5,7,8-hexahydro-6-oxa-cyclopenta [b] naphthalene, 6,7-epoxy-1,1,2,4,4,7-hexamethyl-octahydro-naphthalene, 1,1,2 , 3,3-pentamethyl-1 2,3,5,6,7-hexahydro-inden-4-one, 1- (2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydro- Naphthalen-2-yl) -ethanone, 2,2,3 ′, 7 ′, 7′-pentamethylspiro (1,3-dioxane-5,2′-norcaran), methyl-n-3,7-dimethyl- 7-hydroxyoctylidene anthranilate, 2- [3- (4-tert-butyl-phenyl) -2-methyl-propenylamino] -benzoic acid methyl ester, 2-[(2,4-dimethyl-cyclohex- 3-enylmethylene) -amino] -benzoic acid methyl ester, 2-methyl-4- (2,6,6-trimethyl-cyclohex-2-enyl) -butyraldehyde, 3- (3-isopropyl-phenyl)- Butyrua Dehydr, 3- (4-isobutyl-phenyl) -2-methyl-propionaldehyde, [1-methyl-2- (1,2,2, -trimethyl-bicyclo [3.1.0] hex-3-ylmethyl) -Cyclopropyl] -methanol, 2-ethyl-4- (2,2,3-trimethyl-cyclopent-3-en-1-yl) -but-2-en-1-ol, 3- (5,5, Sun containing 6-trimethylbicyclo [2.2.1] hept-2-yl) cyclohexanol, 3- (5,5,6-trimethylbicyclo [2.2.1] hept-2-yl) cyclohexanol Delaprocess products, 3-methyl-5- (2,2,3-trimethyl-cyclopent-3-enyl) -pentan-2-ol, 3-methyl-5- (2,2,3-trimethyl-3- Cyclopentene -1-yl) -4-penten-2-ol, (e) -oxacycloheptadec-10-en-2-one, 3-methylcyclotetradec-5-en-1-one, 4-methylcyclo Said use selected from the group consisting of tetradec-6-en-1-one and oxacyclohexadec-12-en-2-one. 請求項１に規定された少なくとも１種の皮膚美白化合物および任意に賦形剤を含む組成物を、十分な濃度においてヒトの皮膚に定期的な間隔で適用する、ヒト皮膚を美白する方法。 At least one skin lightening compounds and compositions comprising excipients optionally as defined in claim 1, applied at regular intervals to the skin of humans in a sufficient concentration, a method of lightening human skin. 請求項１に規定された少なくとも１種の皮膚美白化合物を、パーソナルケア製品調合物に０．１〜２％（ｗ／ｖ）の濃度で混合する、皮膚美白パーソナルケア製品を形成する方法。 A method of forming a skin lightening personal care product, wherein at least one skin lightening compound as defined in claim 1 is mixed in a personal care product formulation at a concentration of 0.1-2% (w / v). 第１のステップとして、組成物を、請求項１に規定された皮膚美白化合物から選択される少なくとも１種の化合物、並びに、アルブチン、デオキシアルブチン、オクタデセンジオン酸、コウジ酸、エンブリカニンＡ、エンブリカニンＢ、アスコルビン酸、アスコルビン酸の誘導体、香料成分、溶媒、添加剤、および賦形剤からなる群から選択される少なくとも１種の成分から形成する、請求項３に記載の方法。 As a first step, the composition comprises at least one compound selected from skin lightening compounds as defined in claim 1 and arbutin, deoxyarbutin, octadecenedioic acid, kojic acid, embricanin A, embricanin B The method according to claim 3 , wherein at least one component selected from the group consisting of: ascorbic acid, a derivative of ascorbic acid, a perfume component, a solvent, an additive, and an excipient is formed. （ａ）少なくとも３０％（ｗ／ｗ）の、少なくとも２種の請求項１に規定された皮膚美白化合物、
（ｂ）７０％（ｗ／ｗ）までの、香料において用いられる添加剤、賦形剤および溶媒を含む１種または２種以上の付加的な香料成分から選択される任意の成分、
を含む、皮膚美白香料組成物。 (A) at least 30% (w / w), skin lightening compounds as defined in claim 1 of at least 2,
(B) up to 70% (w / w) any ingredient selected from one or more additional perfume ingredients including additives, excipients and solvents used in perfume,
A skin whitening fragrance composition. （Ｅ）−オキサシクロヘプタデク−１０−エン−２−オンまたは３−メチルシクロテトラデク−５−エン−１−オン、４−メチルシクロテトラデク−６−エン−１−オンおよびオキサシクロヘキサデク−１２−エン−２−オンからなる群から選択される少なくとも１種の化合物、並びに、アルブチン、オクタデセンジオン酸、デオキシアルブチン、コウジ酸、エンブリカニンＡ、エンブリカニンＢ、アスコルビン酸、およびアスコルビン酸の誘導体からなる群から選択される少なくとも１種の皮膚美白化合物を含む、請求項５に記載の皮膚美白香料組成物。 (E) -oxacycloheptadec-10-en-2-one or 3-methylcyclotetradec-5-en-1-one, 4-methylcyclotetradec-6-en-1-one and oxacyclohexa At least one compound selected from the group consisting of dec-12-en-2-one, and arbutin, octadecenedioic acid, deoxyarbutin, kojic acid, embryonicin A, embryonicin B, ascorbic acid, and ascorbic acid The skin whitening fragrance composition according to claim 5 , comprising at least one skin whitening compound selected from the group consisting of derivatives. 請求項５または６に規定された組成物を、パーソナルケア製品調合物と混合する、皮膚美白パーソナルケア製品を製造するための方法。 A method for producing a skin whitening personal care product, wherein the composition as defined in claim 5 or 6 is mixed with a personal care product formulation. 請求項５、６または７に記載の組成物を少なくとも０．１％（ｗ／ｖ）含む、皮膚美白パーソナルケア製品。 A skin whitening personal care product comprising at least 0.1% (w / v) of the composition according to claim 5 , 6 or 7 . 少なくとも２種の請求項１に規定された皮膚美白化合物を、０．１％〜１％の合計濃度で含む、皮膚美白パーソナルケア製品。 A skin lightening personal care product comprising at least two skin lightening compounds as defined in claim 1 in a total concentration of 0.1% to 1%. （Ｅ）−オキサシクロヘプタデク−１０−エン−２−オン、３−メチルシクロテトラデク−５−エン−１−オン、４−メチルシクロテトラデク−６−エン−１−オン、およびオキサシクロヘキサデク−１２−エン−２−オンからなる群から選択される少なくとも１種の皮膚美白化合物、並びに、アルブチン、デオキシアルブチン、オクタデセンジオン酸、コウジ酸、エンブリカニンＡ、エンブリカニンＢ、アスコルビン酸、およびアスコルビン酸の誘導体からなる群から選択される少なくとも１種の化合物を含む、皮膚美白パーソナルケア製品。   (E) -oxacycloheptadec-10-en-2-one, 3-methylcyclotetradec-5-en-1-one, 4-methylcyclotetradec-6-en-1-one, and oxacyclohex At least one skin lightening compound selected from the group consisting of sadec-12-en-2-one, and arbutin, deoxyarbutin, octadecenedioic acid, kojic acid, embryonicin A, embryonicin B, ascorbic acid, and A skin whitening personal care product comprising at least one compound selected from the group consisting of derivatives of ascorbic acid. 皮膚美白パーソナルケア製品の製造方法であって、
ａ）請求項１に規定された少なくとも１種の皮膚美白化合物を、パーソナルケア製品調合物に混合し、パーソナルケア製品を形成することにより、パーソナルケア製品を提供すること、
ｂ）前記パーソナルケア製品を包装すること、
ｃ）前記包装されたパーソナルケア製品に、皮膚の美容美白用の使用説明書を提供すること、
のステップを含む、前記方法。 A method of manufacturing a skin whitening personal care product,
at least one skin lightening compounds as defined in a) claim 1, and mixed in a personal care product formulations, by forming a personal care product, to provide a personal care product,
b) packaging the personal care product;
c) providing the packaged personal care product with instructions for cosmetic skin whitening;
The method comprising the steps of: 使用説明書が、色素が沈着または過度に沈着した皮膚に、パーソナルケア製品を、定期的に皮膚美白効果を得るのに十分な量で適用するためのものである、請求項１１に記載の方法。   12. The method of claim 11, wherein the instructions for use are for applying a personal care product to the pigmented or over-deposited skin in an amount sufficient to periodically obtain a skin lightening effect. . パーソナルケア製品が、請求項１に規定された少なくとも１種の皮膚美白化合物を０．１％〜２％の濃度で有し、使用説明書が、パーソナルケア製品を、色素が沈着または過度に沈着した皮膚にたっぷりと、少なくとも１日１回、好ましくは５〜５０ｍｇ／ｃｍ２の量または０．０５〜０．５ｍｍの厚さで適用するためのものである、請求項１２に記載の方法。 The personal care product has at least one skin lightening compound as defined in claim 1 in a concentration of 0.1% to 2%, and the instructions for use include the personal care product, pigmented or over-deposited. 13. The method of claim 12 , wherein the method is for application to the skin thoroughly and at least once a day, preferably in an amount of 5-50 mg / cm < 2 > or a thickness of 0.05-0.5 mm. 請求項１に規定された化合物を、色素が沈着または過度に沈着したヒトの皮膚に定期的に十分な量で適用することにより、皮膚を美白する方法。 A method of whitening the skin by regularly applying a sufficient amount of a compound as defined in claim 1 to human skin that is pigmented or over-deposited. パーソナルケア製品が、請求項１〜５のいずれかに規定された少なくとも１種の皮膚美白化合物を０．１〜２％の濃度で有し、これを少なくとも１日１回、５〜５０ｍｇ／ｃｍ２の量または０．０５〜０．５ｍｍの厚さで皮膚に適用する、請求項１４に記載の方法。 The personal care product has at least one skin lightening compound as defined in any of claims 1 to 5 in a concentration of 0.1 to 2%, which is at least once a day, 5 to 50 mg / cm. 15. The method of claim 14 , wherein the method is applied to the skin in an amount of 2 or a thickness of 0.05 to 0.5 mm.
JP2008503342A 2005-03-29 2006-03-17 Methods, compositions and products for skin whitening Pending JP2008534524A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0506263.3A GB0506263D0 (en) 2005-03-29 2005-03-29 Skin lightening methods, composition and products
PCT/CH2006/000161 WO2006102777A1 (en) 2005-03-29 2006-03-17 Skin lightening methods, compositions and products

Publications (2)

Publication Number Publication Date
JP2008534524A JP2008534524A (en) 2008-08-28
JP2008534524A5 true JP2008534524A5 (en) 2009-04-23

Family

ID=34566577

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008503342A Pending JP2008534524A (en) 2005-03-29 2006-03-17 Methods, compositions and products for skin whitening

Country Status (5)

Country Link
JP (1) JP2008534524A (en)
KR (1) KR20070116026A (en)
CN (1) CN101151069A (en)
GB (1) GB0506263D0 (en)
WO (1) WO2006102777A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0621805D0 (en) 2006-11-03 2006-12-13 Givaudan Sa Organic compounds
GB0705097D0 (en) * 2007-03-16 2007-04-25 Quest Int Serv Bv Perfume compositions
DE102013204088A1 (en) * 2013-03-11 2014-09-11 Beiersdorf Ag Active ingredient combinations of alkylamidothiazoles and one or more cosmetically or dermatologically relevant fragrances
WO2015159384A1 (en) * 2014-04-16 2015-10-22 株式会社コーセー Novel compound, and cosmetic and topical skin agent comprising same
KR101648739B1 (en) * 2014-07-08 2016-08-17 인하대학교 산학협력단 Composition for skin whitening comprising (4aS,5S,6R,8aS)-5-((R)-3-((((E)-3-(3,4-dihydroxyphenyl)acryloyl)oxy)methyl)-5-hydroxypentyl)-5,6,8a-trimethyl-3,4,4a,5,6,7,8,8a-octahydronaphthalene-1-carboxylic acid as effective component and uses thereof
EP3618799A1 (en) * 2017-05-05 2020-03-11 Firmenich SA Organic hydroperoxide reduction in perfumery raw materials and food raw materials

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69204801D1 (en) * 1991-06-10 1995-10-19 Givaudan Roure Int Hydroxy- oder oxosubstituierte alkylcyclopentene.
JPH07502285A (en) * 1992-09-29 1995-03-09 ジボーダン　−　ルール　（アンテルナシヨナル）ソシエテ　アノニム lactone
JPH08198747A (en) * 1995-01-25 1996-08-06 Pola Chem Ind Inc Melanogeneticity inhibitor and skin preparation for external use
SG63806A1 (en) * 1997-02-14 1999-03-30 Givaudan Roure Int Thiamacrolides
EP0908455B1 (en) * 1997-10-09 2002-07-10 Givaudan SA Macrocycles
SG70655A1 (en) * 1997-10-29 2000-02-22 Givaudan Roure Int New spirocyclic compounds
SG78360A1 (en) * 1998-06-03 2001-02-20 Givaudan Roure Int Bicyclic aldehydes and ketones
DE60001997T2 (en) * 1999-02-19 2004-02-26 Givaudan S.A. 6-Substituted 3-methyloct-6-enols
ATE232847T1 (en) * 1999-05-27 2003-03-15 Givaudan Sa ALPHA, BETA UNSATURATED KETONES
GB9918025D0 (en) * 1999-07-30 1999-09-29 Unilever Plc Skin care composition
EP1216691A1 (en) * 2000-12-23 2002-06-26 Givaudan SA Antibacterial composition comprising a synergistic mixture of a fragrance aldehyde and a preservative
US20020169091A1 (en) * 2001-02-14 2002-11-14 Clare Jonathan Richard Automatic dishwashing compositions comprising blooming perfume and base masking ingredients
US20030036493A1 (en) * 2001-05-01 2003-02-20 The Procter & Gamble Company Stable liquid or gel bleaching composition containing diacyl peroxide particles
JP4828046B2 (en) * 2001-06-08 2011-11-30 高砂香料工業株式会社 Melanin production inhibitor and topical skin preparation
JP2004123709A (en) * 2002-08-06 2004-04-22 Sankodo:Kk Composition having brown pigment-decolorizing activity
ES2431836T3 (en) * 2003-04-23 2013-11-28 The Procter & Gamble Company A composition comprising a cationic polymer that enhances surface deposition
US20040223871A1 (en) * 2003-05-05 2004-11-11 The Procter & Gamble Company Method of freshening air
JP4187707B2 (en) * 2004-02-19 2008-11-26 曽田香料株式会社 Melanin production inhibitor

Similar Documents

Publication Publication Date Title
US6955816B2 (en) Anti-aging skin care composition and uses thereof
AU2015312408B2 (en) Cyclohexanecarboxamide with cooling properties
JP2008534524A5 (en)
MXPA00006311A (en) Compositions and method for protecting skin from uv induced immunosuppression and skin damage.
JP2005506285A5 (en)
TW201338796A (en) Compositions comprising gallates and gallamides
JP2004508351A (en) Resorcinol derivative
JP2022531316A (en) Methods for Forming Encapsulation Complexes with Hydrophilic β-Cyclodextrin Derivatives and Their Compositions
JP2012502020A (en) Cosmetic composition comprising polyhydroxylate (POLYHYDROXYLTATE) fatty alcohol and derivatives and uses thereof
EP3090781A1 (en) Anti-age composition with plant extracts
Bellad et al. Development ofcosmeceuticals
EP3482742A1 (en) Foamable skin composition
JP2009221154A (en) Interleukin-6 production inhibitor
FR2755011A1 (en) USE OF RETINOIC ACID INHIBITORS TO TREAT SENSITIVE SKIN AND / OR ACUTE DAMAGE INDUCED BY U.V. RADIATION
AU2019204136A1 (en) Compositions and methods for treating skin conditions using light and glucosamine hydrochloride
JP2008534524A (en) Methods, compositions and products for skin whitening
JP2006124322A (en) Hyaluronidase inhibitor, skin care composition for external use containing the hyaluronidase inhibitor, and oral composition containing the same
KR102277525B1 (en) Cosmetic or pharmaceutical composition for melanism, elasticity, anti-wrinkle, skin moisturizing or anti-inflammation comprising fargesin
JP6255154B2 (en) Topical skin preparation
FR2974296A1 (en) USE OF A COMBINATION OF A CAROTENOID, A PHYTOESTROGEN AND VITAMIN C AS AN AGENT FOR HYDRATION OF THE SKIN
Mohiuddin An extensive review of sunscreen and suntan preparations
KR101623682B1 (en) Pharmaceutical composition comprising eriodictyol or its pharmaceutically acceptable salts as an active ingredient for preventing or treating contact dermatitis
KR102348707B1 (en) Cosmetic or pharmaceutical composition for skin elasticity, anti-wrinkle, skin moisturizing or anti-inflammation comprising Docetaxel or a pharmaceutically acceptable salt thereof
JP2011246354A (en) Skin external preparation
JP6249598B2 (en) Topical skin preparation